AbbVie Inc.

Pharmaceuticals
United States
Earnings Per Share Growth (%)184.55%
Cost of Goods Sold (US$ Millions)$4,500
Current Liabilities (US$ Millions)$10,894
Total Assets (US$ Millions)$16,314
Long Term Debt$29,240
Return on Equity295.29%
Revenue (US$ Millions)$22,859
Total Company Assets$53,050
Revenue Growth (%)14.52%
Net Income (US$ Millions)$5,144
Earnings Per Share (US$)$184.55
Total Equity (US$ Millions)$3,945
Profit Margin (%)22.50%
Debt To Equity Ratio (%)7.41%
Inventory Turnover$1,719